104-week safety and effectiveness of dupilumab in the treatment of severe atopic dermatitis. The experience of 5 reference dermatology units in Spain

  1. Pereyra-Rodriguez, J.J.
  2. Dominguez-Cruz, J.
  3. Armario-Hita, J.C.
  4. Ruiz-Villaverde, R.
Aldizkaria:
Anais Brasileiros de Dermatologia

ISSN: 1806-4841 0365-0596

Argitalpen urtea: 2021

Alea: 96

Zenbakia: 6

Orrialdeak: 787-790

Mota: Artikulua

DOI: 10.1016/J.ABD.2020.08.030 GOOGLE SCHOLAR lock_openSarbide irekia editor